See more : 1st Federal Savings Bank of SC, Inc. (FSGB) Income Statement Analysis – Financial Results
Complete financial analysis of Surgery Partners, Inc. (SGRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Surgery Partners, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Creso Pharma Limited (CPH.AX) Income Statement Analysis – Financial Results
- Sonos, Inc. (SONO) Income Statement Analysis – Financial Results
- Federal National Mortgage Association (FNMAT) Income Statement Analysis – Financial Results
- ECO HOTELS AND RESORTS LIMITED (ECOHOTELS.BO) Income Statement Analysis – Financial Results
- Montana Aerospace AG (0AAI.L) Income Statement Analysis – Financial Results
Surgery Partners, Inc. (SGRY)
About Surgery Partners, Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.60M | 260.22M |
| Cost of Revenue | 2.10B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.20M | 669.33M | 254.18M | 169.84M | 159.35M |
| Gross Profit | 647.50M | 574.90M | 491.40M | 379.80M | 423.80M | 410.03M | 327.42M | 324.24M | 290.57M | 149.11M | 114.76M | 100.87M |
| Gross Profit Ratio | 23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 24.41% | 28.31% | 30.27% | 36.97% | 40.32% | 38.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Other Expenses | 198.60M | 112.40M | 60.90M | 48.60M | 75.10M | 63.67M | 25.33M | -3.73M | -119.91M | 21.21M | 17.85M | 14.32M |
| Operating Expenses | 319.50M | 214.60M | 164.90M | 145.70M | 163.70M | 157.23M | 156.37M | 123.66M | 111.83M | 52.66M | 44.18M | 39.58M |
| Cost & Expenses | 2.42B | 2.18B | 1.90B | 1.63B | 1.57B | 1.52B | 1.17B | 944.85M | 781.16M | 306.84M | 214.03M | 198.93M |
| Interest Income | 0.00 | 227.00M | 220.90M | 201.80M | 178.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 193.00M | 234.90M | 221.00M | 201.80M | 178.90M | 147.00M | 117.67M | 100.57M | 100.98M | 62.10M | 32.93M | 28.48M |
| Depreciation & Amortization | 118.10M | 149.60M | 137.90M | 134.20M | 116.50M | 67.44M | 51.93M | 39.55M | 34.55M | 15.06M | 11.66M | 11.21M |
| EBITDA | 446.10M | 460.00M | 401.00M | 277.80M | 336.60M | 144.68M | 251.88M | 245.23M | 59.39M | 65.87M | 69.89M | 72.49M |
| EBITDA Ratio | 16.26% | 19.86% | 20.32% | 18.35% | 18.81% | 18.58% | 19.00% | 21.05% | 10.12% | 27.96% | 28.89% | 27.86% |
| Operating Income | 328.00M | 345.20M | 302.20M | 246.60M | 235.90M | 77.84M | 158.23M | 196.48M | 144.75M | 50.81M | 58.23M | 60.45M |
| Operating Income Ratio | 11.96% | 13.59% | 13.58% | 13.26% | 12.88% | 4.39% | 11.80% | 17.15% | 15.08% | 12.60% | 20.46% | 23.23% |
| Total Other Income/Expenses | -193.00M | -234.90M | -221.00M | -201.80M | -181.30M | -147.00M | -75.95M | -104.30M | -220.89M | -62.10M | -32.93M | -29.31M |
| Income Before Tax | 135.00M | 110.30M | 81.20M | -18.80M | 54.60M | -69.17M | 82.29M | 92.18M | -76.14M | -11.29M | 25.30M | 31.97M |
| Income Before Tax Ratio | 4.92% | 4.34% | 3.65% | -1.01% | 2.98% | -3.90% | 6.14% | 8.05% | -7.93% | -2.80% | 8.89% | 12.29% |
| Income Tax Expense | 300.00K | 23.30M | 10.50M | -20.10M | 8.50M | 26.46M | 53.55M | 7.10M | -148.98M | 15.76M | 7.57M | 6.11M |
| Net Income | -11.90M | 87.00M | 70.70M | 1.30M | 46.10M | -205.71M | -52.99M | 9.45M | 1.43M | -65.90M | -9.06M | 1.92M |
| Net Income Ratio | -0.43% | 3.43% | 3.18% | 0.07% | 2.52% | -11.61% | -3.95% | 0.83% | 0.15% | -16.34% | -3.18% | 0.74% |
| EPS | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| EPS Diluted | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.08 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| Weighted Avg Shares Out | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.69M | 48.02M | 36.07M | 48.16M | 48.16M | 48.16M |
| Weighted Avg Shares Out (Dil) | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 49.00M | 48.19M | 37.46M | 48.16M | 48.16M | 48.16M |
Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q2 2021 Results - Earnings Call Transcript
Surgery Partners: Q2 Earnings Insights
Surgery Partners, Inc. Announces Second Quarter 2021 Earnings Release Date and Conference Call Details
7 Healthcare Stocks to Buy for Changing Demographics
Surgery Partners, Inc. and UCI Health Announce New Strategic Partnership
Surgery Partners, Inc. to Present at Upcoming Investor Conference
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q1 2021 Results - Earnings Call Transcript
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
Surgery Partners, Inc. Announces Term Loan Refinancing and Conversion of Preferred Stock; Provides Preliminary First Quarter 2021 Financial Performance Update
Source: https://incomestatements.info
Category: Stock Reports